The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Child With Respiratory Paralysis from Accident Receives Phrenic Nerve Stimulation Implant

Dec. 12, 2018 - A 7-year-old boy from Kenya who received a cervical spine injury when hit by a motor vehicle, and required mechanical ventilation, received a phrenic nerve stimulator and was weaned off the ventilator in India, allowing him to become more mobile one year after his injury. He will receive follow-up care in his own country. (Specialty Medical Dialogues)

Company Announces an FDA Head-Only MRI-Conditional Approval

Dec. 12, 2018 - Nuvectra announced it received FDA head-only conditional approval for its spinal cord stimulation system. (Neuro News)

Company Seeks CE Mark for Device to Treat Balance Deficit

Dec. 12, 2018 - A noninvasive device for the treatment of chronic balance deficit due to mild to moderate traumatic brain injury is subject to a CE mark application. The application was made by a subsidiary of the device company Helius Medical Technologies, Inc. (Globe Newswire)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM